Human Recombinant CDKL3 protein, GST Tag (V2LY-0526-LY3067)

Zeng, D. X., Sheng, G. F., Liu, Y. P., Zhang, Y. P., Qian, Z., Li, Z., & Bi, Y. Z. (2021). Cyclin-dependent kinase like 3 promotes triple-negative breast cancer progression via inhibiting the p53 signaling pathway. Neoplasma.

Yan, S., Wei, H., Li, Q., Si, M., Feng, W., & Chen, Z. (2021). CircTP53 promotes colorectal cancer by acting as a miR-876-3p sponge to increase cyclin-dependent kinase-like 3 expression. Cellular Signalling, 78, 109845.

Cui, Y., Yang, Z., Wang, H., Yan, Y., Huang, Q., Gong, Z., ... & Xu, T. (2021). Identification of CDKL3 as a critical regulator in development of glioma through regulating RRM2 and the JNK signaling pathway. Cancer science, 112(8), 3150.

Sun, Q., Zhang, X., Tan, Z., Gu, H., Ding, S., & Ji, Y. (2021). Bone marrow mesenchymal stem cells-secreted exosomal microRNA-205–5p exerts inhibitory effect on the progression of liver cancer through regulating CDKL3. Pathology-Research and Practice, 225, 153549.

He, A., Ma, L., Huang, Y., Zhang, H., Duan, W., Li, Z., ... & Xiang, D. (2020). CDKL3 promotes osteosarcoma progression by activating Akt/PKB. Life science alliance, 3(5).

Zhou, S., Zhang, M., Zhou, C., Wang, W., Yang, H., & Ye, W. (2020). CDKL3 Targets ATG5 to Promote Carcinogenesis of Esophageal Squamous Cell Carcinoma. Frontiers in Oncology, 10, 1602.

Zhang, J., Su, G., Tang, Z., Wang, L., Fu, W., Zhao, S., ... & Xie, X. (2018). Curcumol exerts anticancer effect in cholangiocarcinoma cells via down-regulating CDKL3. Frontiers in physiology, 9, 234.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols